| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Carmine Pariante | Q49754517 |
| Kuan-Pin Su | Q56509488 | ||
| P2093 | author name string | Valeria Mondelli | |
| Jane Pei-Chen Chang | |||
| P2860 | cites work | Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments | Q22241854 |
| Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents | Q24202221 | ||
| Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. | Q50528223 | ||
| Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial. | Q50653409 | ||
| A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. | Q52124551 | ||
| Clinical characteristics and serum essential fatty acid levels in hyperactive children. | Q52255772 | ||
| Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial | Q59621760 | ||
| A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids | Q59664128 | ||
| Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder | Q71774534 | ||
| A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD | Q73256558 | ||
| Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women | Q80580097 | ||
| Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study | Q80783516 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD | Q28301651 | ||
| Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis | Q28315392 | ||
| Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder | Q33807435 | ||
| Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study | Q34002508 | ||
| A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids | Q34005609 | ||
| The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension | Q34205335 | ||
| Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. | Q34218148 | ||
| Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels | Q34315488 | ||
| Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study | Q34468355 | ||
| The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder | Q34529904 | ||
| Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. | Q34777746 | ||
| Parent-teacher agreement on ADHD symptoms across development. | Q35831643 | ||
| Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis | Q35946312 | ||
| Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study | Q36510618 | ||
| Essential fatty acids: biochemistry, physiology and pathology | Q36558089 | ||
| A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression | Q37746266 | ||
| Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials | Q38190255 | ||
| Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial | Q38391449 | ||
| Serum cytokines in paediatric neuropsychiatric syndromes: focus on Attention Deficit Hyperactivity Disorder | Q39071786 | ||
| Polyunsaturated Fatty Acids in Perinatal Depression: A Systematic Review and Meta-analysis | Q39243282 | ||
| Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection | Q40855688 | ||
| Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression | Q41752567 | ||
| Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials | Q41960525 | ||
| Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder | Q41987116 | ||
| Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial | Q42233349 | ||
| EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. | Q43057323 | ||
| Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men. | Q43276836 | ||
| A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder | Q43697347 | ||
| Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder | Q44104559 | ||
| Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder | Q44458626 | ||
| EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors | Q44689298 | ||
| The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study | Q44957795 | ||
| Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan | Q45012026 | ||
| Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder | Q46115737 | ||
| Arachidonic acid improves aged rats' spatial cognition. | Q46423001 | ||
| Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol | Q46772955 | ||
| The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues | Q46912892 | ||
| Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). | Q48151053 | ||
| The fatty acid profile of buccal cheek cell phospholipids is a noninvasive marker of long-chain polyunsaturated Fatty Acid status in piglets | Q48520690 | ||
| Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. | Q49123199 | ||
| Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study | Q49212922 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| attention deficit hyperactivity disorder | Q181923 | ||
| systematic review | Q1504425 | ||
| attention | Q6501338 | ||
| P304 | page(s) | 534-545 | |
| P577 | publication date | 2017-07-25 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies | |
| P478 | volume | 43 |
| Q47916180 | A case series on the potential effect of omega-3-fatty acid supplementation on 24-h heart rate variability and its circadian variation in children with attention deficit (hyperactivity) disorder |
| Q92462687 | Deficiency or activation of peroxisome proliferator-activated receptor α reduces the tissue concentrations of endogenously synthesized docosahexaenoic acid in C57BL/6J mice |
| Q92712439 | Elevated Gestational IL-13 During Fetal Development Is Associated With Hyperactivity and Inattention in Eight-Year-Old Children |
| Q91344452 | High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels |
| Q92813908 | Microencapsulated Tuna Oil Results in Higher Absorption of DHA in Toddlers |
| Q89660081 | Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development |
| Q91893886 | Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study |
| Q47890984 | Omega-3 fatty acid deficiency impairs frontostriatal recruitment following repeated amphetamine treatment in rats: A 7 Tesla in vivo phMRI study |
| Q90169497 | Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials |
| Q47235837 | Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials. |
| Q91995146 | PUFA and their derivatives in neurotransmission and synapses: a new hallmark of synaptopathies |
| Q98499753 | Polygenic risk score analysis revealed shared genetic background in attention deficit hyperactivity disorder and narcolepsy |
| Q92898011 | Popular Herbal and Natural Remedies Used in Psychiatry |
| Q61806045 | Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders |
| Q61809229 | Situating adult attention-deficit/hyperactivity disorder in the externalizing spectrum: Etiological, diagnostic, and treatment considerations |
| Q64987380 | Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. |
| Q64327441 | Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) |
| Q90379698 | The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders |
| Q93181443 | The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials |
| Q64954197 | The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. |
| Q99572001 | The stress-Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches |
| Q93135895 | Trim the fat: the role of omega-3 fatty acids in psychopharmacology |
| Q92714978 | Use of Dietary Supplements among Spanish Pediatricians in Daily Practice: A Cross-Sectional Survey Study |
Search more.